Search filters
Filters
Clear All

Phase

  • 2
  • 2
  • 3
  • 3
  • 4

Found 7 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

AutoRun24

100 years or below
Male
AutomationRun0179
about the study

AutoRun24

100 years or below
Male
AutomationRun0179
Check Eligibility

Test_Trial_Card

18 years - 100 years
Accepts healthy volunteer
Male
Phase 2
AutomationRun0180
Check Eligibility

Enteral Feeding and Splanchnic NIRS Values in Infants With Neonatal Encephalopathy (NE)

2 days or below
All genders
Interventional
The research team plans to administer trophic enteral feeds to infants with Neonatal Encephalopathy that are undergoing therapeutic hypothermia. The team will monitor splanchnic NIRS values and compare these values to a group of historic infants who underwent hypothermia but did not receive feeds, to investigate whether there may be …
about the study

Prospective Randomized Placebo-Controlled Trial of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE) (SURVIVE)

18 years or above
All genders
Phase 2
Interventional
The primary purpose of this study is to determine whether adding SurVaxM to standard chemotherapy with temozolomide is better than treatment with temozolomide alone for patients with newly diagnosed glioblastoma. This study is designed to compare the duration of survival in patients with newly diagnosed glioblastoma receiving temozolomide plus SurVaxM …
about the study

S0820, Adenoma and Second Primary Prevention Trial (PACES)

18 years or above
All genders
Phase 3
Interventional
The investigators hypothesize that the combination of eflornithine and sulindac will be effective in reducing the event rate of adenomas and second primary colorectal cancers at three years in patients previously treated for stage 0 to III colon or rectal cancer.
about the study

ZEUS A research study to see how Ziltivekimab works compared to placebo in patients with cardiovascular disease, chronic kidney disease and inflammation (ZEUS)

18 years or above
All genders
Phase 3
Interventional
The purpose of this study is to see if the new study drug, Ziltivekimab, can be used to treat people with cardiovascular disease, chronic kidney disease, and inflammation. The ZEUS study will see if Ziltivekimab can reduce the risk of having cardiovascular events (for example, heart attack and stroke). The …
Check Eligibility